AGIO | Agios PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$31.20
+$1.25 (+4.17%)

Agios Pharmaceuticals (AGIO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2026, but the two have been closing on each other and a death cross is projected within 30 bars. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
below both $30.55 vs 50 $30.78 / 200 $32.38
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 31 Aug 2026 ยท projected 10 bars out ยท tested 4 bars

4-hour as of 3 Nov 16:00 ET

Price
below both $31.20 vs 50 $33.47 / 200 $34.61
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Oct 2026 ยท projected 11 bars out

Cross history

33
crosses on record since 2017
16 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2026Death4-hour11 bars outNot tested
week of 31 Aug 2026Death flatweekly10 bars out4 bar cross test
14 Jul 2026Golden steepdaily27 bars outNot tested
18 Jun 2026Golden4-hour15 bars outNot tested
15 May 2026Death4-hour29 bars out5 bar cross test

About AGIO

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$32.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.